SHB has previously been described in contexts of tumor angiogenesis [26, 32], vascular leakage [26, 27], myeloid infiltration [39] and T cell responses [30] and we thus considered it appropriate to study the effects of Shb-deficiency in the 4T1 breast carcinoma model. This evidence concerns the gene SHB and neoplasm.